- AU$96.45m
- AU$70.94m
- $0.39m
- 33
- 41
- 59
- 43
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 6 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | fx Final | Final |
Revenue | |||||
Total Revenue | 0.233 | 0.285 | 0.131 | 0.038 | 0.393 |
Cost of Revenue | |||||
Gross Profit | -1.48 | -0.409 | -0.374 | -0.355 | -0.056 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 4.7 | 3.89 | 1.8 | 1.73 | 1.26 |
Operating Profit | -4.46 | -3.6 | -1.67 | -1.69 | -0.866 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.42 | -3.67 | -3.85 | 0.309 | -3.36 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.43 | -3.68 | -3.86 | 0.306 | -3.36 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -4.32 | -3.65 | -3.85 | 0.311 | -3.36 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.32 | -3.65 | -3.85 | 0.311 | -3.36 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.014 | -0.008 | -0.008 | 0.001 | -0.007 |
Dividends per Share |